Search research articles
Contact Us
Filters
Showing results (321-330 of 353) with videos related to
Page
of 36
Sort By:
The Lancet. Neurology
|
March 23, 2011
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
Peter A LeWitt, Ali R Rezai, Maureen A Leehey, et al.
Brain Communications
|
March 21, 2025
<i>LRRK2</i>-associated parkinsonism with and without <i>in vivo</i> evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization
Lana M Chahine, David-Erick Lafontant, Seung Ho Choi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 3, 2026
Effects of α-synuclein pathology on synaptic dysfunction and clinical outcomes in normal aging
Joseph R Winer, Melanie J Plastini, America Romero, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 7, 2024
LRRK2-Associated Parkinsonism With and Without <i>In Vivo</i> Evidence of Alpha-Synuclein Aggregates
Lana M Chahine, David-Erick Lafontant, Seung Ho Choi, et al.
Neurology
|
February 2, 2024
Evaluation of ATN<sub>PD</sub> Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease
Katheryn A Q Cousins, David J Irwin, Thomas F Tropea, et al.
JCI Insight
|
April 14, 2017
Long-term follow-up of a randomized AAV2-<i>GAD</i> gene therapy trial for Parkinson's disease
Martin Niethammer, Chris C Tang, Peter A LeWitt, et al.
Cell Reports Methods
|
April 29, 2025
Accurate prediction of absolute prokaryotic abundance from DNA concentration
Jakob Wirbel, Tessa M Andermann, Erin F Brooks, et al.
NPJ Parkinson'S Disease
|
April 10, 2026
Plasma phosphorylated tau 217 detects amyloid-β in neuronal synuclein disease
Alena M Smith, Sara A Lorkiewicz, Burak Arslan, et al.
NPJ Parkinson'S Disease
|
September 27, 2024
Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts
Tien Dam, Gennaro Pagano, Michael C Brumm, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 24, 2024
Neuronal alpha-Synuclein Disease Integrated Staging System performance in PPMI, PASADENA, and SPARK baseline cohorts
Tien Dam, Gennaro Pagano, Michael C Brumm, et al.
Page
of 36
Search research articles
Search
Showing results (321-330 of 353) with videos related to
Sort By:
Page
of 36
The Lancet. Neurology
|
March 23, 2011
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
Peter A LeWitt, Ali R Rezai, Maureen A Leehey, et al.
Brain Communications
|
March 21, 2025
<i>LRRK2</i>-associated parkinsonism with and without <i>in vivo</i> evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization
Lana M Chahine, David-Erick Lafontant, Seung Ho Choi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 3, 2026
Effects of α-synuclein pathology on synaptic dysfunction and clinical outcomes in normal aging
Joseph R Winer, Melanie J Plastini, America Romero, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 7, 2024
LRRK2-Associated Parkinsonism With and Without <i>In Vivo</i> Evidence of Alpha-Synuclein Aggregates
Lana M Chahine, David-Erick Lafontant, Seung Ho Choi, et al.
Neurology
|
February 2, 2024
Evaluation of ATN<sub>PD</sub> Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease
Katheryn A Q Cousins, David J Irwin, Thomas F Tropea, et al.
JCI Insight
|
April 14, 2017
Long-term follow-up of a randomized AAV2-<i>GAD</i> gene therapy trial for Parkinson's disease
Martin Niethammer, Chris C Tang, Peter A LeWitt, et al.
Cell Reports Methods
|
April 29, 2025
Accurate prediction of absolute prokaryotic abundance from DNA concentration
Jakob Wirbel, Tessa M Andermann, Erin F Brooks, et al.
NPJ Parkinson'S Disease
|
April 10, 2026
Plasma phosphorylated tau 217 detects amyloid-β in neuronal synuclein disease
Alena M Smith, Sara A Lorkiewicz, Burak Arslan, et al.
NPJ Parkinson'S Disease
|
September 27, 2024
Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts
Tien Dam, Gennaro Pagano, Michael C Brumm, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 24, 2024
Neuronal alpha-Synuclein Disease Integrated Staging System performance in PPMI, PASADENA, and SPARK baseline cohorts
Tien Dam, Gennaro Pagano, Michael C Brumm, et al.
Page
of 36